Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology
- 1 December 1993
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 49 (12) , 1064-1072
- https://doi.org/10.1007/bf01929915
Abstract
It is thought that impairment, of energy metabolism that results in deterioration of membrane function, leading to loss of the Mg2+ block on NMDA receptors, and allowing persistent activation of these receptors by glutamate, might be a cause of neuronal death in neurodegenerative disorders. Studies in rodents using mitochondrial respiratory chain toxins, such as aminooxyacetic acid, 1-methyl-4-phenylpyridinium, malonic acid and 3-nitropropionic acid, suggest that such processes may indeed be involved in neurotoxicity. Striatal and nigral degeneration induced by mitochondrial toxins in rodents resembles the neuropathology seen in humans suffering from Huntington's or Parkinson's disease, and can be prevented either by decortication or by NMDA receptor antagonists. Such experimental observations suggest that glutamate may be involved in neuronal death leading to neurodegenerative disorders in humans. If so, glutamate antagonists may offer a therapeutic approach for retarding the progression of these disabling disorders.Keywords
This publication has 80 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Inhibition of Succinate Dehydrogenase by Malonic Acid Produces an “Excitotoxic” Lesion in Rat StriatumJournal of Neurochemistry, 1993
- Neurotoxic Effects of Sodium Nitroprusside in Rat Hippocampal SlicesExperimental Neurology, 1993
- Mitochondrial Impairment Reduces the Threshold for in Vivo NMDA-Mediated Neuronal Death in the StriatumExperimental Neurology, 1993
- The N‐Methyl‐D‐Aspartate Antagonist MK‐801 Fails to Protect Dopaminergic Neurons from 1‐Methyl‐4‐ Phenylpyridinium Toxicity In VitroJournal of Neurochemistry, 1993
- Basic Fibroblast Growth Factor Protects against Hypoxia-Ischemia and NMDA Neurotoxicity in Neonatal RatsJournal of Cerebral Blood Flow & Metabolism, 1993
- Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in miceNeuroscience Letters, 1992
- MK‐801 Fails to Protect Against the Dopaminergic Neuropathology Produced by Systemic 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mice or Intranigral 1‐Methyl‐4‐Phenylpyridinium in RatsJournal of Neurochemistry, 1992
- Intracerebroventricular administration of 1-methyl-4-phenylpyridinium ion in mice: Effects of simultaneously administered nomifensine, deprenyl, and 1-t-butyl-4,4-diphenylpiperidineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- BASAL GANGLIA DEGENERATION, MYELIN ALTERATIONS, AND ENZYME INHIBITION INDUCED IN MICE BY THE PLANT TOXIN 3‐NITROPROPANOIC ACIDNeuropathology and Applied Neurobiology, 1982